Hydralazine

  • TRADE NAMES: Alphapress; Apdormin; Apresazide (Novartis); Apresolin; Apresoline (Novartis); Novo-Hylazin; Nu-Hydral; Ser-Ap-Es (Novartis); Solesorin; Stable
  • INDICATIONS: Hypertension
  • CLASS: Vasodilator
  • HALF-LIFE: 3–7 hours

Apresazide is hydralazine and hydrochlorothiazide; Ser-Ap-Es is hydralazine, reserpine and hydrochlorothiazide.

Hydrochlorothiazide is a sulfonamide and can be absorbed systemically. Sulfonamides can produce severe, possibly fatal, reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome.

Our database has 38 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
RENAL
HEMATOLOGIC
OTHER


Page last updated 09/25/2017

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric